BIO-TECHNE Corp Quarterly Goodwill in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
BIO-TECHNE Corp quarterly Goodwill history and growth rate from Q2 2010 to Q3 2024.
  • BIO-TECHNE Corp Goodwill for the quarter ending September 30, 2024 was $983M, a 1.36% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $983M +$13.2M +1.36% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $973M +$99.9M +11.5% Jun 30, 2024 10-Q 2024-11-05
Q1 2024 $971M +$100M +11.5% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $980M +$110M +12.7% Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $969M +$104M +12% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $873M +$50.6M +6.16% Jun 30, 2023 10-K 2024-08-22
Q1 2023 $871M +$42.9M +5.19% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $870M +$37.5M +4.51% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 $865M +$22.4M +2.65% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $822M -$21M -2.49% Jun 30, 2022 10-K 2024-08-22
Q1 2022 $828M +$81.2M +10.9% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $832M +$104M +14.2% Dec 31, 2021 10-Q 2022-02-07
Q3 2021 $843M +$111M +15.2% Sep 30, 2021 10-Q 2022-02-07
Q2 2021 $843M +$115M +15.8% Jun 30, 2021 10-K 2023-08-23
Q1 2021 $746M +$20.6M +2.84% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $728M -$5.93M -0.81% Dec 31, 2020 10-Q 2021-05-07
Q3 2020 $732M +$1.22M +0.17% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $728M -$4.36M -0.6% Jun 30, 2020 10-K 2022-08-24
Q1 2020 $726M +$6.22M +0.87% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $734M +$27.9M +3.95% Dec 31, 2019 10-Q 2020-02-06
Q3 2019 $730M +$25.6M +3.64% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $733M +$135M +22.5% Jun 30, 2019 10-K 2021-08-25
Q1 2019 $720M +$109M +17.8% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $706M +$117M +19.9% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $705M +$117M +19.9% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $598M +$18.9M +3.26% Jun 30, 2018 10-K 2020-08-26
Q1 2018 $611M +$40.9M +7.18% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $589M +$31.4M +5.63% Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $588M +$22M +3.89% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $579M +$148M +34.4% Jun 30, 2017 10-K/A 2019-11-06
Q1 2017 $570M +$135M +31.1% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $558M +$134M +31.6% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $566M +$138M +32.4% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $431M +$40.2M +10.3% Jun 30, 2016 10-K 2018-08-27
Q1 2016 $435M +$48.9M +12.7% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $424M +$22.2M +5.54% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $427M +$122M +40% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $391M +$239M +158% Jun 30, 2015 10-K 2017-09-07
Q1 2015 $386M +$241M +167% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $402M +$257M +178% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $305M +$161M +112% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $151M +$67.1M +79.6% Jun 30, 2014 10-K 2016-08-29
Q1 2014 $145M +$60.3M +71.6% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $144M +$57.2M +65.6% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 $144M +$56.9M +65.4% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $84.3M -$1.35M -1.57% Jun 30, 2013 10-K 2015-08-31
Q1 2013 $84.3M -$2.21M -2.56% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $87.2M +$1.93M +2.26% Dec 31, 2012 10-Q 2013-02-11
Q3 2012 $86.9M +$1.58M +1.85% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $85.7M -$951K -1.1% Jun 30, 2012 10-K 2014-08-29
Q1 2012 $86.5M +$61.5M +245% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $85.2M +$60.2M +240% Dec 31, 2011 10-Q 2012-02-07
Q3 2011 $85.4M +$60.3M +241% Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $86.6M +$61.6M +246% Jun 30, 2011 10-K 2013-08-29
Q1 2011 $25.1M Mar 31, 2011 10-Q 2011-05-10
Q4 2010 $25.1M Dec 31, 2010 10-Q 2011-02-09
Q3 2010 $25.1M Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $25.1M Jun 30, 2010 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.